Excimer Lamp Versus Excimer Laser in Vitiligo Treatment
Comparative Study of 308nm Excimer Lamp and 308nm Excimer Laser in the Treatment of Vitiligo
1 other identifier
interventional
N/A
1 country
1
Brief Summary
308 nm excimer lamp and 308 nm excimer laser have both provide interesting results in treating vitiligo. They have the same wavelength but the type of emission of the photons is different. To date there is no direct comparative data concerning these two devices in this indication. The aim of the study is to make an intra-individual prospective comparison between these two phototherapies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 10, 2008
CompletedFirst Posted
Study publicly available on registry
June 12, 2008
CompletedOctober 31, 2008
October 1, 2008
June 10, 2008
October 30, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Repigmentation rate in the treated areas
12 weeks
Secondary Outcomes (1)
Tolerance and safety of the treatments
12 weeks
Study Arms (2)
A
ACTIVE COMPARATOR308 nm excimer lamp
B
ACTIVE COMPARATOR308 nm excimer laser
Interventions
50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks
50 mJ/cm² below the MED (minimal erythemal dose) and progressive increase Twice a week for 12 weeks (same doses will be used between the 2 arms)
Eligibility Criteria
You may qualify if:
- patient above 18
- vitiligo for more than 3 months
- at least 2 vitiligo symmetric patches more than 10cm²
- to read and understand the inform consent
- to have a social security number
- non pregnant for women
You may not qualify if:
- pregnant women
- keloids
- history of radiotherapy or skin cancer in the treated areas
- treatment for vitiligo in the past 4 weeks
- phototherapy in the past 12 weeks; history of photodermatosis
- treatment inducing photosensibilization
- immunosuppression
- patient who participated in a study in the past 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Dermatology, University Hospital of Nice
Nice, 06200, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 10, 2008
First Posted
June 12, 2008
Last Updated
October 31, 2008
Record last verified: 2008-10